FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Per Venge

Research Profile

Anatomy

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Jenny Rubin; Per Venge
Asparagine-linked glycans determine the cytotoxic capacity of eosinophil cationic protein (ECP).
Kai M Eggers; Bertil Lindahl; Per Venge; Lars Lind
Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population.
Kai M Eggers; Per Venge; Lars Lind
Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Per Venge (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jenny Rubin; Per Venge
Asparagine-linked glycans determine the cytotoxic capacity of eosinophil cationic protein (ECP).
Molecular immunology 2013;55(3-4):372-80.
2013: Kai M Eggers; Bertil Lindahl; Per Venge; Lars Lind
Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population.
Journal of the American College of Cardiology 2013;61(18):1906-13.
2013: Kai M Eggers; Per Venge; Lars Lind
Mid-regional pro-atrial natriuretic peptide levels in the elderly: clinical and prognostic implications, and comparison to B-type natriuretic peptides.
Clinica chimica acta; international journal of clinical chemistry 2013;419():62-6.
2013: Johanna Helmersson-Karlqvist; Erik Ingelsson; Anders Larsson; Lars Lind; Johan Sundström; Per Venge; Axel C Carlsson; Johan Arnlöv
Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men.
Atherosclerosis 2013;227(2):408-13.
2013: M Karawajczyk; C G B Peterson; Per Venge; Rodolfo C Garcia
An extragranular compartment of blood eosinophils contains eosinophil protein X/eosinophil-derived neurotoxin (EPX/EDN).
Inflammation 2013;36(2):320-9.
2013: Anna M Nordenskjöld; Per Venge; Håkan Ahlström; Kai M Eggers; Ole Fröbert; Allan S Jaffe; Bertil Lindahl
Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease.
Clinical chemistry 2013;59(2):401-9.
2013: Kai M Eggers; Per Venge; Lars Lind
Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
The American journal of cardiology 2013;111(1):131-6.
2012: Kristin Blom; Lena Douhan Håkansson; Jonas Halfvarson; Ulla-Britt Jönsson; Mikael Lördal; Anders Rönnblom; Jenny Rubin; Per Sangfelt; Urban Sjöqvist; Leif Törkvist; Per Venge; Marie Carlson
Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.
World journal of gastroenterology : WJG 2012;18(44):6409-19; discussion p. 6417-8.
2012: Johan Mårtensson; Claes-Roland Martling; Max Bell; Shengyuan Xu; Per Venge
Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils.
Clinica chimica acta; international journal of clinical chemistry 2012;413(19-20):1661-7.
2012: Roland Bingisser; Charles Cairns; Michael Christ; Pierre Hausfater; Bertil Lindahl; Johannes Mair; Mauro Panteghini; Christopher Price; Per Venge
Cardiac troponin: a critical review of the case for point-of-care testing in the ED.
The American journal of emergency medicine 2012;30(8):1639-49.
2012: Kristian Thygesen; Marco Tubaro; Per Venge; Joseph S Alpert; Luigi M Biasucci; Stefan Blankenberg; Paul Collinson; Marcello Galvani; Evangelos Giannitsis; Christian Hamm; Yonathan Hasin; Kurt Huber; Allan S Jaffe; Hugo Katus; Wolfgang Koenig; Bertil Lindahl; Johannes Mair; Christian Mueller; Mario Plebani
How to use high-sensitivity cardiac troponins in acute cardiac care.
European heart journal 2012;33(18):2252-7.
2012: Kristian Thygesen; Marco Tubaro; Per Venge; Michael Weber; Joseph S Alpert; Luigi M Biasucci; Paul Collinson; Marcello Galvani; Evangelos Giannitsis; Christian Hamm; Yonathan Hasin; Kurt Huber; Allan S Jaffe; Hugo Katus; Wolfgang Koenig; Bertil Lindahl; Johannes Mair; Christian Mueller; Mario Plebani
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.
European heart journal 2012;33(16):2001-6.
2012: Kai M Eggers; Per Venge; Bertil Lindahl
High-sensitive cardiac troponin T outperforms novel diagnostic biomarkers in patients with acute chest pain.
Clinica chimica acta; international journal of clinical chemistry 2012;413(13-14):1135-40.
2012: Shengyuan Xu; Linshu Zhao; Lars Lind; Bertil Lindahl; Per Venge
Plasma prolylcarboxypeptidase (angiotensinase C) is increased in obesity and diabetes mellitus and related to cardiovascular dysfunction.
Clinical chemistry 2012;58(7):1110-5.
2012: Mona Bafadhel; Michael R Barer; Sebastian L Johnston; David A Lomas; Susan McKenna; Vijay Mistry; Mitesh Pancholi; Ian D Pavord; Sarah Terry; Per Venge; Christopher E Brightling
Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial.
American journal of respiratory and critical care medicine 2012;186(1):48-55.
2012: Tanja Savukoski; Per Venge; Saara Wittfooth; Noora Ristiniemi; Kai M Eggers; Janne Engblom; Emilia Engström; Bertil Lindahl; Kim Pettersson
Troponin-specific autoantibody interference in different cardiac troponin I assay configurations.
Clinical chemistry 2012;58(6):1040-8.
2012: Malin Svensson; Per Venge; Christer Janson; Eva Lindberg
Relationship between sleep-disordered breathing and markers of systemic inflammation in women from the general population.
Journal of sleep research 2012;21(2):147-54.
2012: Kai M Eggers; Per Venge
Utility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalities.
Pathology 2012;44(2):129-38.
2011: Ingrid Glimelius; Henrik Hjalgrim; Daniel Molin; Klaus Rostgaard; Jenny Rubin; Martin Simonsson; Karin Ekström Smedby; Karina M Sorensen; Per Venge; Rose-Marie Amini; Gunilla Enblad
Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin's lymphoma--a population-based study.
European journal of haematology 2011;87(3):208-16.
2011: Kai M Eggers; Tomas Jernberg; Magnus Nygren; Per Venge; Bernt G Wikström
High-sensitive troponin T and I are related to invasive hemodynamic data and mortality in patients with left-ventricular dysfunction and precapillary pulmonary hypertension.
Clinica chimica acta; international journal of clinical chemistry 2011;412(17-18):1582-8.
2011: Ingrid Glimelius; Daniel Molin; Jenny Rubin; Per Venge; Rose-Marie Amini; Marie Fischer; Gunilla Enblad
Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines.
Experimental hematology 2011;39(8):850-8.
2011: Raquel Espregueira Themudo; Bertil Lindahl; Lars Johansson; Per Venge; Håkan Ahlström; Charlotte Ebeling Barbier; Kai M Eggers; Lars Lind; Tomas Bjerner
Unrecognized myocardial scars detected by delayed-enhanced MRI are associated with increased levels of NT-proBNP.
Coronary artery disease 2011;22(3):158-64.
2011: Michael Haase; Prasad Devarajan; Anja Haase-Fielitz; Rinaldo Bellomo; Dinna N Cruz; Gebhard Wagener; Catherine D Krawczeski; Jay L Koyner; Patrick Murray; Michael Zappitelli; Stuart L Goldstein; Konstantinos Makris; Claudio Ronco; Johan Martensson; Claes-Roland Martling; Per Venge; Edward Siew; Lorraine B Ware; T Alp Ikizler; Peter R Mertens
The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies.
Journal of the American College of Cardiology 2011;57(17):1752-61.
2011: Amir I Elshafie; Erik Hlin; Lena Douhan Håkansson; Gehad Elghazali; Sayda Hassan El Safi; Johan Rönnelid; Per Venge
Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis.
International journal for parasitology 2011;41(3-4):463-9.
2011: Marie Carlson; Per Venge; Maria Lampinen
C3b-induced eosinophil degranulation involves PI3-kinases and is inhibited by protein kinase C activity.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2011;119(2):119-26.
2011: Søren Hjortshøj; Per Venge; Jan Ravkilde
Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays.
Clinica chimica acta; international journal of clinical chemistry 2011;412(3-4):370-5.
2011: Kai M Eggers; Allan S Jaffe; Per Venge; Bertil Lindahl
Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction.
Clinica chimica acta; international journal of clinical chemistry 2011;412(1-2):91-7.
2010: Linjun Cai; Jenny Rubin; Wenyu Han; Per Venge; Shengyuan Xu
The origin of multiple molecular forms in urine of HNL/NGAL.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(12):2229-35.
2010: Bertil Lindahl; Per Venge; Kai M Eggers; Rolf Gedeborg; Noora Ristiniemi; Saara Wittfooth; Kim Pettersson
Autoantibodies to cardiac troponin in acute coronary syndromes.
Clinica chimica acta; international journal of clinical chemistry 2010;411(21-22):1793-8.
2010: Per Venge; Claes Ohberg; Mats Flodin; Bertil Lindahl
Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I.
American heart journal 2010;160(5):835-41.
2010: H Kloster Smerud; Bengt Fellström; Roger Hällgren; S Osagie; Per Venge; Gudjón Kristjánsson
Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy.
Clinical nephrology 2010;74(5):364-71.
2010: Kristian Thygesen; Johannes Mair; Hugo Katus; Mario Plebani; Per Venge; Paul Collinson; Bertil Lindahl; Evangelos Giannitsis; Yonathan Hasin; Marcello Galvani; Marco Tubaro; Joseph S Alpert; Luigi M Biasucci; Wolfgang Koenig; Christian Mueller; Kurt Huber; Christian Hamm; Allan S Jaffe
Recommendations for the use of cardiac troponin measurement in acute cardiac care.
European heart journal 2010;31(18):2197-204.
2010: Bertil Lindahl; Per Venge; Stefan James
The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes.
American heart journal 2010;160(2):224-9.
2010: Johan Mårtensson; Max Bell; Anders Oldner; Shengyuan Xu; Per Venge; Claes-Roland Martling
Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury.
Intensive care medicine 2010;36(8):1333-40.
2010: Kai M Eggers; Tibor Kempf; Per Venge; Lars Wallentin; Kai C Wollert; Bertil Lindahl
Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers.
American heart journal 2010;160(1):88-94.
2010: Per Venge
The eosinophil and airway remodelling in asthma.
The clinical respiratory journal 2010;4 Suppl 1():15-9.
2010: Kai M Eggers; Paul W Armstrong; Robert M Califf; Maarten L Simoons; Per Venge; Lars Wallentin; Stefan K James
ST2 and mortality in non-ST-segment elevation acute coronary syndrome.
American heart journal 2010;159(5):788-94.
2010: Stefan Gustafsson; Lars Lind; Björn Zethelius; Per Venge; Allan Flyvbjerg; Siv Söderberg; Erik Ingelsson
Adiponectin and cardiac geometry and function in elderly: results from two community-based cohort studies.
European journal of endocrinology / European Federation of Endocrine Societies 2010;162(3):543-50.
2010: Shengyuan Xu; Linjun Cai; Linshu Zhao; Lena Douhan-Håkansson; Gudjon Kristjánsson; Karlis Pauksen; Per Venge
Tissue localization and the establishment of a sensitive immunoassay of the newly discovered human phospholipase B-precursor (PLB-P).
Journal of immunological methods 2010;353(1-2):71-7.
2010: Kai M Eggers; Tibor Kempf; Bo Lagerqvist; Bertil Lindahl; Sylvia Olofsson; Franziska Jantzen; Timo Peter; Tim Allhoff; Agneta Siegbahn; Per Venge; Kai C Wollert; Lars Wallentin
Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome.
Circulation. Cardiovascular genetics 2010;3(1):88-96.
2010: Kai M Eggers; Mikael Dellborg; Nina Johnston; Jonas Oldgren; Eva Swahn; Per Venge; Bertil Lindahl
Myeloperoxidase is not useful for the early assessment of patients with chest pain.
Clinical biochemistry 2010;43(3):240-5.
2010: Ulla-Britt Jönsson; Lena Douhan Håkansson; Rain Jõgi; Christer Janson; Per Venge
Associations of ECP (eosinophil cationic protein)-gene polymorphisms to allergy, asthma, smoke habits and lung function in two Estonian and Swedish sub cohorts of the ECRHS II study.
BMC pulmonary medicine 2010;10():36.
2009: Lars Lind; Lars Wallentin; Tibor Kempf; Heike Tapken; Anja Quint; Bertil Lindahl; Sylvia Olofsson; Per Venge; Anders Larsson; Johannes Hulthe; Anders Elmgren; Kai C Wollert
Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study.
European heart journal 2009;30(19):2346-53.
2009: Per Venge; Nina Johnston; Bertil Lindahl; Stefan James
Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.
Journal of the American College of Cardiology 2009;54(13):1165-72.
2009: C Woschnagg; Jenny Rubin; Per Venge
Eosinophil cationic protein (ECP) is processed during secretion.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(6):3949-54.
2009: Hilde Kloster Smerud; Bengt Fellström; Roger Hällgren; Sonia Osagie; Per Venge; Gudjón Kristjánsson
Gluten sensitivity in patients with IgA nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2009;24(8):2476-81.
2009: Kai M Eggers; Bo Lagerqvist; Per Venge; Lars Wallentin; Bertil Lindahl
Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
Journal of the American College of Cardiology 2009;54(4):357-64.
2009: Jenny Rubin; Ulrika Zagai; Kristin Blom; Agneta Trulson; Ake Engström; Per Venge
The coding ECP 434(G>C) gene polymorphism determines the cytotoxicity of ECP but has minor effects on fibroblast-mediated gel contraction and no effect on RNase activity.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(1):445-51.
2009: C Woschnagg; Johan Forsberg; Ake Engström; Federico Odreman; Per Venge; Rodolfo C Garcia
The human eosinophil proteome. Changes induced by birch pollen allergy.
Journal of proteome research 2009;8(6):2720-32.
2009: Linjun Cai; Jan Borowiec; Shengyuan Xu; Wenyu Han; Per Venge
Assays of urine levels of HNL/NGAL in patients undergoing cardiac surgery and the impact of antibody configuration on their clinical performances.
Clinica chimica acta; international journal of clinical chemistry 2009;403(1-2):121-5.
2009: Kai M Eggers; Bertil Lindahl; Per Venge; Lars Lind
B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years.
The American journal of cardiology 2009;103(7):1032-8.
2009: Ulrika Zagai; Joachim Lundahl; Julius Klominek; Per Venge; C Magnus Sköld
Eosinophil cationic protein stimulates migration of human lung fibroblasts in vitro.
Scandinavian journal of immunology 2009;69(4):381-6.
2009: Johan Sundström; Erik Ingelsson; Lars Berglund; Björn Zethelius; Lars Lind; Per Venge; Johan Arnlöv
Cardiac troponin-I and risk of heart failure: a community-based cohort study.
European heart journal 2009;30(7):773-81.
2009: Kai M Eggers; Lars Lind; Per Venge; Bertil Lindahl
Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction?
The American journal of cardiology 2009;103(5):588-91.
2009: Per Venge; Johan Arnlöv; Björn Zethelius
Seemingly healthy 71-year-old men with minor elevations of cardiac troponin I and at risk of premature death in CVD have elevated levels of NT-proBNP: report from the ULSAM study.
Scandinavian journal of clinical and laboratory investigation 2009;69(3):418-24.
2008: Kai M Eggers; Bo Lagerqvist; Jonas Oldgren; Per Venge; Lars Wallentin; Bertil Lindahl
Pathophysiologic mechanisms of persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome.
American heart journal 2008;156(3):588-94.
2008: Kai M Eggers; Lars Lind; Håkan Ahlström; Tomas Bjerner; Charlotte Ebeling Barbier; Anders Larsson; Per Venge; Bertil Lindahl
Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects.
European heart journal 2008;29(18):2252-8.
2008: Kai M Eggers; Mikael Dellborg; Jonas Oldgren; Eva Swahn; Per Venge; Bertil Lindahl
Risk prediction in chest pain patients by biochemical markers including estimates of renal function.
International journal of cardiology 2008;128(2):207-13.
2008: M Lidén; Gudjón Kristjánsson; S Valtysdottir; Per Venge; Roger Hällgren
Cow's milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren's syndrome.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2008;38(6):929-35.
2008: Björn Zethelius; Lars Berglund; Johan Sundström; Erik Ingelsson; Samar Basu; Anders Larsson; Per Venge; Johan Arnlöv
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
The New England journal of medicine 2008;358(20):2107-16.
2008: Karlis Pauksens; Gustav Fjaertoft; Lena Douhan-Håkansson; Per Venge
Neutrophil and monocyte receptor expression in uncomplicated and complicated influenza A infection with pneumonia.
Scandinavian journal of infectious diseases 2008;40(4):326-37.
2007: Jenny Eriksson; Charlotte Woschnagg; Eva Fernvik; Per Venge
A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein.
Journal of leukocyte biology 2007;82(6):1491-500.
2007: Kai M Eggers; Bo Lagerqvist; Per Venge; Lars Wallentin; Bertil Lindahl
Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
Circulation 2007;116(17):1907-14.
2007: Ruby Cooray; Karin Persson Waller; Per Venge
Haptoglobin comprises about 10% of granule protein extracted from bovine granulocytes isolated from healthy cattle.
Veterinary immunology and immunopathology 2007;119(3-4):310-5.
2007: Kai C Wollert; Tibor Kempf; Bo Lagerqvist; Bertil Lindahl; Sylvia Olofsson; Tim Allhoff; Timo Peter; Agneta Siegbahn; Per Venge; Helmut Drexler; Lars Wallentin
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome.
Circulation 2007;116(14):1540-8.
2007: Ulrika Zagai; Elham Dadfar; Joachim Lundahl; Per Venge; C Magnus Sköld
Eosinophil cationic protein stimulates TGF-beta1 release by human lung fibroblasts in vitro.
Inflammation 2007;30(5):153-60.
2007: Jenny Eriksson; Claus Reimert; Narcis B Kabatereine; Francis Kazibwe; Edmund Ireri; Hilda Kadzo; Hanan B Eltahir; Abdelrahim O Mohamed; Birgitte J Vennervald; Per Venge
The 434(G>C) polymorphism within the coding sequence of Eosinophil Cationic Protein (ECP) correlates with the natural course of Schistosoma mansoni infection.
International journal for parasitology 2007;37(12):1359-66.
2007: Eythór Björnsson; Dóra Lúdvíksdóttir; Hans Hedenström; Britt-Marie Eriksson; Marieann Högman; Per Venge; Christer Janson
Airway hyperresponsiveness, peak flow variability and inflammatory markers in non-asthmatic subjects with respiratory infections.
The clinical respiratory journal 2007;1(1):42-50.
2007: Li-Jun Tang; Francesco De Seta; Federico Odreman; Per Venge; Caterina Piva; Secondo Guaschino; Rodolfo Garcia
Proteomic analysis of human cervical-vaginal fluids.
Journal of proteome research 2007;6(7):2874-83.
2007: Gudjón Kristjánsson; Per Venge; Roger Hällgren
Mucosal reactivity to cow's milk protein in coeliac disease.
Clinical and experimental immunology 2007;147(3):449-55.
2007: Gunilla Wieslander; Dan Norbäck; Per Venge
Changes of symptoms, tear film stability and eosinophilic cationic protein in nasal lavage fluid after re-exposure to a damp office building with a history of flooding.
Indoor air 2007;17(1):19-27.
2007: Agneta Trulson; Jonas Byström; Ake Engström; R Larsson; Per Venge
The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2007;37(2):208-18.
2007: Gerd Rundström; Ann Jonsson; Ola Mårtensson; Ib Mendel-Hartvig; Per Venge
Lateral flow immunoassay using Europium (III) chelate microparticles and time-resolved fluorescence for eosinophils and neutrophils in whole blood.
Clinical chemistry 2007;53(2):342-8.
2007: Gustav Fjaertoft; Lena Håkansson; Karlis Pauksens; Gregor Sisask; Per Venge
Neutrophil CD64 (FcgammaRI) expression is a specific marker of bacterial infection: a study on the kinetics and the impact of major surgery.
Scandinavian journal of infectious diseases 2007;39(6-7):525-35.
2006: Amir Ibrahim ElShafie; Gehad Elghazali; Johan Rönnelid; Per Venge
Cystatin C as a marker of immune complex-associated renal impairment in a Sudanese population with visceral leishmaniasis.
The American journal of tropical medicine and hygiene 2006;75(5):864-8.
2006: Maria Lampinen; Gunnar Oberg; Per Venge; Marie Carlson
Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2006;114(11):757-63.
2006: Stefan K James; Johan Lindbäck; Johanna Tilly; Agneta Siegbahn; Per Venge; Paul Armstrong; Robert M Califf; Maarten L Simoons; Lars Wallentin; Bertil Lindahl
Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.
Journal of the American College of Cardiology 2006;48(6):1146-54.
2006: Erik Björklund; Tomas Jernberg; Per Johanson; Per Venge; Mikael Dellborg; Lars Wallentin; Bertil Lindahl
Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction.
Heart (British Cardiac Society) 2006;92(6):735-40.
2006: Stefan James; Mats Flodin; Nina Johnston; Bertil Lindahl; Per Venge
The antibody configurations of cardiac troponin I assays may determine their clinical performance.
Clinical chemistry 2006;52(5):832-7.
2006: Tomas Jernberg; Kurt Boman; Stefan James; Bertil Lindahl; Mats Stridsberg; Karl Swedberg; Per Venge
[BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation].
Läkartidningen 2006;103(17):1289-92, 1295.
2006: Ulla-Britt Jönsson; Jonas Byström; Gunnemar Stålenheim; Per Venge
A (G->C) transversion in the 3' UTR of the human ECP (eosinophil cationic protein) gene correlates to the cellular content of ECP.
Journal of leukocyte biology 2006;79(4):846-51.
2006: Mia Furebring; Lena Håkansson; Per Venge; Jan Sjölin
C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes.
Scandinavian journal of immunology 2006;63(3):208-16.
2006: Björn Zethelius; Nina Johnston; Per Venge
Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.
Circulation 2006;113(8):1071-8.
2006: Maria Lampinen; Lena Håkansson; Per Venge
Albumin stimulation of eosinophil migration involves PI3-kinases and is associated with diminished eosinophil CD49d and CD49f expression.
International archives of allergy and immunology 2006;140(2):113-20.
2005: Kawa Amin; Christer Janson; Ilkka T Harvima; Per Venge; Gunnar Nilsson
CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma.
The Journal of allergy and clinical immunology 2005;116(6):1383-6.
2005: Robert Wålinder; Lena Ernstgård; Gunnar Johanson; Dan Norbäck; Per Venge; Gunilla Wieslander
Acute effects of a fungal volatile compound.
Environmental health perspectives 2005;113(12):1775-8.
2005: Kawa Amin; Christer Janson; Gunnar Boman; Per Venge
The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma.
Allergy 2005;60(10):1241-7.
2005: Bo Lagerqvist; Erik Diderholm; Bertil Lindahl; S Husted; Fredrik Kontny; Elisabeth Ståhle; Eva Swahn; Per Venge; Agneta Siegbahn; Lars Wallentin
FRISC score for selection of patients for an early invasive treatment strategy in unstable coronary artery disease.
Heart (British Cardiac Society) 2005;91(8):1047-52.
2005: Anders Vahlquist; Per Westermark; Elisabeth Ståhle; Per Venge; Lars Påhlman; Roger Hällgren; Lars Rönnblom; Kämpe Olle; Lars Wiklund; Sten-Magnus Aquilonius; Albert Alm
[Burdensome rules for clinical trials are not in proportion to benefits for the patient].
Läkartidningen 2005;102(23):1832, 1834; discussion 1834.
2005: Gustav Fjaertoft; Tony Foucard; Shengyuan Xu; Per Venge
Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetics.
Acta paediatrica (Oslo, Norway : 1992) 2005;94(6):661-6.
2005: Gudjon Kristjansson; Jordi Serra; Lars Lööf; Per Venge; Roger Hällgren
Kinetics of mucosal granulocyte activation after gluten challenge in coeliac disease.
Scandinavian journal of gastroenterology 2005;40(6):662-9.
2005: Tomas Jernberg; Stefan James; Bertil Lindahl; Mats Stridsberg; Per Venge; Lars Wallentin
NT-ProBNP in non-ST-elevation acute coronary syndrome.
Journal of cardiac failure 2005;11(5 Suppl):S54-8.
2005: Gudjón Kristjánsson; Marieann Högman; Per Venge; Roger Hällgren
Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn.
Gut 2005;54(6):769-74.
2005: Shengyuan Xu; Linshu Zhao; Anders Larsson; Emanuel Smeds; Marion Kusche-Gullberg; Per Venge
Purification of a 75 kDa protein from the organelle matrix of human neutrophils and identification as N-acetylglucosamine-6-sulphatase.
The Biochemical journal 2005;387(Pt 3):841-7.
2005: Shahida Shahana; Einar Björnsson; D Lúdvíksdóttir; Christer Janson; OS Nettelbladt; Per Venge; Godfried M Roomans
Ultrastructure of bronchial biopsies from patients with allergic and non-allergic asthma.
Respiratory medicine 2005;99(4):429-43.
2005: Gustav Fjaertoft; Lena Håkansson; Tony Foucard; Uwe Ewald; Per Venge
CD64 (Fcgamma receptor I) cell surface expression on maturing neutrophils from preterm and term newborn infants.
Acta paediatrica (Oslo, Norway : 1992) 2005;94(3):295-302.
2005: Bertil Lindahl; Johan Lindbäck; Tomas Jernberg; Nina Johnston; Mats Stridsberg; Per Venge; Lars Wallentin
Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy.
Journal of the American College of Cardiology 2005;45(4):533-41.
2005: Gustav Fjaertoft; Karlis Pauksen; Lena Håkansson; Shengyuan Xu; Per Venge
Cell surface expression of FcgammaRI (CD64) on neutrophils and monocytes in patients with influenza A, with and without complications.
Scandinavian journal of infectious diseases 2005;37(11-12):882-9.
2005: Kawa Amin; Christer Janson; Lahja Sevéus; Kaoru Miyazaki; Ismo Virtanen; Per Venge
Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics.
Respiratory research 2005;6():110.
2005: Stefan Ivanov; Lena Palmberg; Per Venge; Kjell Larsson; Anders Lindén
Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust.
Respiratory research 2005;6():44.
2005: Ann Ekberg-Jansson; Kawa Amin; Björn Bake; Annika Rosengren; Ulf Tylen; Per Venge; Claes-Göran AH Löfdahl
Bronchial mucosal mast cells in asymptomatic smokers relation to structure, lung function and emphysema.
Respiratory medicine 2005;99(1):75-83.
2005: Christer Janson; Dora Ludviksdottir; María Gunnbjörnsdottir; Eythor H Björnsson; Lena Håkansson; Per Venge
Circulating adhesion molecules in allergic and non-allergic asthma.
Respiratory medicine 2005;99(1):45-51.
2004: Gudjón Kristjánsson; Per Venge; A Wanders; Lars Lööf; Roger Hällgren
Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome.
Gut 2004;53(12):1806-12.
2004: C Woschnagg; Per Venge; Rodolfo C Garcia
The effect of IL-5 treatment on the stimulation-induced phosphorylation of proteins in blood eosinophils.
Cytokine 2004;28(3):137-48.
2004: Mia Furebring; Lena Håkansson; Per Venge; Jan Sjölin
Differential expression of the C5a receptor and complement receptors 1 and 3 after LPS stimulation of neutrophils and monocytes.
Scandinavian journal of immunology 2004;60(5):494-9.
2004: Linshu Zhao; Shengyuan Xu; Gustav Fjaertoft; Karlis Pauksen; Lena Håkansson; Per Venge
An enzyme-linked immunosorbent assay for human carcinoembryonic antigen-related cell adhesion molecule 8, a biological marker of granulocyte activities in vivo.
Journal of immunological methods 2004;293(1-2):207-14.
2004: Tomas Jernberg; Stefan James; Bertil Lindahl; Nina Johnston; Mats Stridsberg; Per Venge; Lars Wallentin
Natriuretic peptides in unstable coronary artery disease.
European heart journal 2004;25(17):1486-93.
2004: Maria Lampinen; M Carlson; L D Håkansson; Per Venge
Cytokine-regulated accumulation of eosinophils in inflammatory disease.
Allergy 2004;59(8):793-805.
2004: Linshu Zhao; Mia Furebring; Shengyuan Xu; Per Venge
Subcellular localization and mobilization of carcinoembryonic antigen-related cell adhesion molecule 8 in human neutrophils.
British journal of haematology 2004;125(5):666-73.
2004: Stefan James; Bertil Lindahl; Agneta Siegbahn; Mats Stridsberg; Per Venge; Lars Wallentin
[Prognosis in unstable coronary artery disease. Multimarker strategy is the best basis for the therapeutic choice].
Läkartidningen 2004;101(17):1514-9, 1521-2.
2004: Tomas Jernberg; Stefan James; Bertil Lindahl; Mats Stridsberg; Per Venge; Lars Wallentin
NT-proBNP in unstable coronary artery disease--experiences from the FAST, GUSTO IV and FRISC II trials.
European journal of heart failure 2004;6(3):319-25.
2004: Ulrika Zagai; C Magnus Sköld; A Trulson; Per Venge; Joachim Lundahl
The effect of eosinophils on collagen gel contraction and implications for tissue remodelling.
Clinical and experimental immunology 2004;135(3):427-33.
2004: Jens Hohlfeld; Andreas Schmiedl; Veit J Erpenbeck; Per Venge; Norbert Krug
Eosinophil cationic protein alters pulmonary surfactant structure and function in asthma.
The Journal of allergy and clinical immunology 2004;113(3):496-502.
2004: Nina Johnston; Tomas Jernberg; Bertil Lindahl; Johan Lindbäck; Mats Stridsberg; Anders Larsson; Per Venge; Lars Wallentin
Biochemical indicators of cardiac and renal function in a healthy elderly population.
Clinical biochemistry 2004;37(3):210-6.
2004: Stefan K James; Bertil Lindahl; Paul Armstrong; Robert M Califf; Maarten L Simoons; Per Venge; Lars Wallentin
A rapid troponin I assay is not optimal for determination of troponin status and prediction of subsequent cardiac events at suspicion of unstable coronary syndromes.
International journal of cardiology 2004;93(2-3):113-20.
2004: Erik Björklund; Bertil Lindahl; Per Johanson; Tomas Jernberg; Ann-Marie Svensson; Per Venge; Lars Wallentin; Mikael Dellborg
Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction.
European heart journal 2004;25(2):113-20.
2004: Per Venge
Monitoring the allergic inflammation.
Allergy 2004;59(1):26-32.
2003: Tomas Jernberg; Bertil Lindahl; Agneta Siegbahn; Bertil Andren; Gunnar Frostfeldt; Bo Lagerqvist; Mats Stridsberg; Per Venge; Lars Wallentin
N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease.
Journal of the American College of Cardiology 2003;42(11):1909-16.
2003: Per Venge; Lena Moberg; Einar Björnsson; Mats Bergström; Bengt Långström; Lena Håkansson
Mechanisms of basal and cytokine-induced uptake of glucose in normal human eosinophils: relation to apoptosis.
Respiratory medicine 2003;97(10):1109-19.
2003: Kristina Seton; Lena Håkansson; Per Venge
Enhanced adhesion to laminin by apoptotic eosinophils.
Scandinavian journal of immunology 2003;58(4):412-8.
2003: Kristina Seton; Lena Håkansson; M Karawajczyk; Per Venge
The stimulus-dependent release of eosinophil cationic protein and eosinophil protein x increases in apoptotic eosinophils.
Scandinavian journal of immunology 2003;58(3):312-20.
2003: Stefan James; Paul Armstrong; Robert M Califf; Maarten L Simoons; Per Venge; Lars Wallentin; Bertil Lindahl
Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial.
The American journal of medicine 2003;115(3):178-84.
2003: Kristina Seton; Lena Håkansson; Marie Carlson; Gunnemar Stålenheim; Per Venge
Apoptotic eosinophils express IL-2R chains alpha and beta and co-stimulatory molecules CD28 and CD86.
Respiratory medicine 2003;97(8):893-902.
2003: Stefan K James; Bertil Lindahl; Agneta Siegbahn; Mats Stridsberg; Per Venge; Paul Armstrong; Elliot S Barnathan; Robert M Califf; Eric J Topol; Maarten L Simoons; Lars Wallentin
N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
Circulation 2003;108(3):275-81.
2003: Abdelrahim O Mohammed; Gehad Elghazali; Hassabo B Mohammed; Mustafa I Elbashir; Shengyuan Xu; Klavs Berzins; Per Venge
Human neutrophil lipocalin: a specific marker for neutrophil activation in severe Plasmodium falciparum malaria.
Acta tropica 2003;87(2):279-85.
2003: Per Venge; Nina Johnston; Bo Lagerqvist; Lars Wallentin; Bertil Lindahl
Clinical and analytical performance of the liaison cardiac troponin I assay in unstable coronary artery disease, and the impact of age on the definition of reference limits. A FRISC-II substudy.
Clinical chemistry 2003;49(6 Pt 1):880-6.
2003: Lixin Liu; Lena Hakansson; Peter Ridefelt; Rodolfo C Garcia; Per Venge
Priming of eosinophil migration across lung epithelial cell monolayers and upregulation of CD11b/CD18 are elicited by extracellular Ca2+.
American journal of respiratory cell and molecular biology 2003;28(6):713-21.
2003: Stefan K James; Paul Armstrong; Elliot S Barnathan; Robert M Califf; Bertil Lindahl; Agneta Siegbahn; Maarten L Simoons; Eric J Topol; Per Venge; Lars Wallentin
Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy.
Journal of the American College of Cardiology 2003;41(6):916-24.
2003: Lene Holmvang; Peter Clemmensen; Bertil Lindahl; Bo Lagerqvist; Per Venge; Galen Wagner; Lars Wallentin; Peer Grande
Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment.
Journal of the American College of Cardiology 2003;41(6):905-15.
2003: Kawa Amin; Ann Ekberg-Jansson; Claes-Göran AH Löfdahl; Per Venge
Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.
Thorax 2003;58(2):135-42.
2003: Tomas Jernberg; Per Venge; Bertil Lindahl
Comparison between second and third generation troponin T assay in patients with symptoms suggestive of an acute coronary syndrome but without ST segment elevation.
Cardiology 2003;100(1):29-35.
2003: Anders Lannergård; Kristina Hersio; Anders Larsson; Karlis Pauksen; Per Venge; Elisabeth Ståhle; Göran Friman
Evaluation of laboratory markers for the detection of infections in open-heart surgery patients.
Scandinavian journal of infectious diseases 2003;35(2):121-6.
2002: Linshu Zhao; Shengyuan Xu; Christer Peterson; Motomu Kuroki; Masahide Kuroki; Per Venge
Purification and characterization of a 95-kDa protein--carcinoembryonic antigen-related cell adhesion molecule 8--from normal human granulocytes.
Journal of immunological methods 2002;270(1):27-35.
2002: Ruth E Aldridge; Tim Chan; Christine J van Dalen; Revathy Senthilmohan; Marti Winn; Per Venge; G Ian Town; Anthony J Kettle
Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics.
Free radical biology & medicine 2002;33(6):847-56.
2002: Tomas Jernberg; Mats Stridsberg; Per Venge; Bertil Lindahl
N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.
Journal of the American College of Cardiology 2002;40(3):437-45.
2002: Mia Furebring; Lena Håkansson; Per Venge; Bo Nilsson; Jan Sjölin
Expression of the C5a receptor (CD88) on granulocytes and monocytes in patients with severe sepsis.
Critical care (London, England) 2002;6(4):363-70.
2002: U-B Jönsson; Jonas Byström; Gunnemar Stålenheim; Per Venge
Polymorphism of the eosinophil cationic protein-gene is related to the expression of allergic symptoms.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(7):1092-5.
2002: Jonas Byström; Rodolfo C Garcia; Lena Håkansson; M Karawajczyk; Lena Moberg; J Soukka; Per Venge
Eosinophil cationic protein is stored in, but not produced by, peripheral blood neutrophils.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2002;32(7):1082-91.
2002: Denise Uettwiller-Geiger; Alan H B Wu; Fred S Apple; Anthony W Jevans; Per Venge; Marilyn D Olson; Claude Darte; David L Woodrum; Sean Roberts; Stephen Chan
Multicenter evaluation of an automated assay for troponin I.
Clinical chemistry 2002;48(6 Pt 1):869-76.
2002: Erik Diderholm; Bertil Andrén; Gunnar Frostfeldt; Margareta Genberg; Tomas Jernberg; Bo Lagerqvist; Bertil Lindahl; Per Venge; Lars Wallentin
The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy.
American heart journal 2002;143(5):760-7.
2002: David S Hurst; Per Venge
The impact of atopy on neutrophil activity in middle ear effusion from children and adults with chronic otitis media.
Archives of otolaryngology--head & neck surgery 2002;128(5):561-6.
2002: Per Venge; Bo Lagerqvist; Erik Diderholm; Bertil Lindahl; Lars Wallentin
Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy).
The American journal of cardiology 2002;89(9):1035-41.
2002: Tuula Metso; Per Venge; Tari Haahtela; C G B Peterson; Lahja Sevéus
Cell specific markers for eosinophils and neutrophils in sputum and bronchoalveolar lavage fluid of patients with respiratory conditions and healthy subjects.
Thorax 2002;57(5):449-51.
2002: Marie Carlson; Yngve Raab; Lahja Sevéus; Shengyuan Xu; Roger Hällgren; Per Venge
Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis.
Gut 2002;50(4):501-6.
2001: Sabina Rak; C Heinrich; L Jacobsen; Annika Scheynius; Per Venge
A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma.
The Journal of allergy and clinical immunology 2001;108(6):921-8.
2001: Kawa Amin; D Lúdvíksdóttir; Christer Janson; OS Nettelbladt; B Gudbjörnsson; S Valtysdóttir; Einar Björnsson; Godfried M Roomans; Gunnar Boman; Lahja Sevéus; Per Venge
Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome.
Respiratory medicine 2001;95(11):904-10.
2001: Inger Dahlén; Christer Janson; Einar Björnsson; Gunnemar Stålenheim; C G B Peterson; Per Venge
Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease.
Respiratory medicine 2001;95(11):891-7.
2001: Bertil Lindahl; Erik Diderholm; Bo Lagerqvist; Per Venge; Lars Wallentin
Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy.
Journal of the American College of Cardiology 2001;38(4):979-86.
2001: Matilda Lampinen; Marie Carlson; Per Sangfelt; Yesuf Taha; Magnus Thörn; Lars Lööf; Yngve Raab; Per Venge
IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis.
Digestive diseases and sciences 2001;46(9):2004-9.
2001: Daniel Molin; Marie Fischer; Zou Xiang; U Larsson; Ilkka T Harvima; Per Venge; Kenneth Nilsson; Christer Sundström; Gunilla Enblad; Gunnar Nilsson
Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
British journal of haematology 2001;114(3):616-23.
2001: Daniel Molin; Bengt Glimelius; Christer Sundström; Per Venge; Gunilla Enblad
The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
Leukemia & lymphoma 2001;42(3):457-65.
2001: Jonas Byström; Taavo Tenno; Lena Håkansson; Kawa Amin; Agneta Trulson; E Högbom; Per Venge
Monocytes, but not macrophages, produce the eosinophil cationic protein.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2001;109(7-8):507-16.
2001: Lena Moberg; M Karawajczyk; Per Venge
(99m)Tc-HMPAO (Ceretec) is stored in and released from the granules of eosinophil granulocytes.
British journal of haematology 2001;114(1):185-90.
2001: C Woschnagg; Rodolfo C Garcia; Per Venge
The mechanisms of serum-treated zymosan (STZ)-induced oxidative metabolism by human eosinophils and the effects of IL-5 priming.
Allergy 2001;56(7):639-45.
2001: Ann Ekberg-Jansson; B Andersson; Björn Bake; M Boijsen; I Enanden; Annika Rosengren; Bengt-Eric Skoogh; Ulf Tylen; Per Venge; Claes-Göran AH Löfdahl
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT.
Respiratory medicine 2001;95(5):363-73.
2001: Gunnar Frostfeldt; G Gustafsson; Bertil Lindahl; Anders Nygren; Per Venge; Lars Wallentin
Possible reasons for the prognostic value of troponin-T on admission in patients with ST-elevation myocardial infarction.
Coronary artery disease 2001;12(3):227-37.
2001: Per Venge; Bertil Lindahl; Lars Wallentin
New generation cardiac troponin I assay for the access immunoassay system.
Clinical chemistry 2001;47(5):959-61.
2001: C Woschnagg; R Garcia; S Rak; Per Venge
IL-5 priming of the PMA-induced oxidative metabolism of human eosinophils from allergic and normal subjects during a pollen season.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2001;31(4):555-64.
2001: Robert Wålinder; Dan Norbäck; Gunilla Wieslander; Greta Smedje; C Erwall; Per Venge
Acoustic rhinometry and lavage biomarkers in relation to some building characteristics in Swedish schools.
Indoor air 2001;11(1):2-9.
2001: Maria Lampinen; Lena Håkansson; Per Venge
Interleukin-2 inhibits eosinophil migration but is counteracted by IL-5 priming.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2001;31(2):249-58.
2001: Kawa Amin; J Rinne; Tari Haahtela; Markku Simola; C G B Peterson; Godfried M Roomans; Henrik Malmberg; Per Venge; Lahja Sevéus
Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration.
The Journal of allergy and clinical immunology 2001;107(2):249-57.
2001: L Kulander; Karlis Pauksens; Per Venge
Soluble adhesion molecules, cytokines and cellular markers in serum in patients with acute infections.
Scandinavian journal of infectious diseases 2001;33(4):290-300.
2001: Robert Wålinder; Dan Norbäck; B Wessen; Per Venge
Nasal lavage biomarkers: effects of water damage and microbial growth in an office building.
Archives of environmental health 2001;56(1):30-6.
2000: Robert Wålinder; Dan Norbäck; Gunilla Wieslander; Greta Smedje; C Erwall; Per Venge
Acoustic rhinometry in epidemiological studies--nasal reactions in Swedish schools.
Rhinology. Supplement 2000;16():59-64.
2000: Gunilla Wieslander; Torsten Lindgren; Dan Norbäck; Per Venge
Changes in the ocular and nasal signs and symptoms of aircrews in relation to the ban on smoking on intercontinental flights.
Scandinavian journal of work, environment & health 2000;26(6):514-22.
2000: Kawa Amin; D Lúdvíksdóttir; Christer Janson; OS Nettelbladt; Einar Björnsson; Godfried M Roomans; Gunnar Boman; Lahja Sevéus; Per Venge
Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group.
American journal of respiratory and critical care medicine 2000;162(6):2295-301.
2000: Bertil Lindahl; H Toss; Agneta Siegbahn; Per Venge; Lars Wallentin
Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease.
The New England journal of medicine 2000;343(16):1139-47.
2000: Shengyuan Xu; Per Venge
Lipocalins as biochemical markers of disease.
Biochimica et biophysica acta 2000;1482(1-2):298-307.
2000: Irmeli Nupponen; Per Venge; Maija Pohjavuori; Patrik Lassus; Sture Andersson
Phagocyte activation in preterm infants following premature rupture of the membranes or chorioamnionitis.
Acta paediatrica (Oslo, Norway : 1992) 2000;89(10):1207-12.
2000: M Karawajczyk; Lahja Sevéus; R Garcia; Einar Björnsson; C G B Peterson; Godfried M Roomans; Per Venge
Piecemeal degranulation of peripheral blood eosinophils: a study of allergic subjects during and out of the pollen season.
American journal of respiratory cell and molecular biology 2000;23(4):521-9.
2000: Robert Wålinder; Gunilla Wieslander; Dan Norbäck; C Erwall; Per Venge
Influence of personal factors on nasal patency and lavage biomarkers in white-collar workers.
Rhinology 2000;38(3):130-5.
2000: K Sandström; Lena Håkansson; Agneta Lukinius; Per Venge
A method to study apoptosis in eosinophils by flow cytometry.
Journal of immunological methods 2000;240(1-2):55-68.
2000: Mika Lahtinen; Jan Borowiec; Per Venge; P Henze; H Stiernström
Nitric oxide increases leukocyte granule release during simulated extracorporeal circulation.
The Thoracic and cardiovascular surgeon 2000;48(3):151-6.
2000: A Björk; Per Venge; C G B Peterson
Measurements of ECP in serum and the impact of plasma coagulation.
Allergy 2000;55(5):442-8.
2000: D S Hurst; Per Venge
Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy.
Allergy 2000;55(5):435-41.
2000: Jan Borowiec; Mika Lahtinen; Per Venge; A Henze; H Stiernström
Inflammatory response during simulated extracorporeal circulation with addition of nitric oxide.
The Journal of cardiovascular surgery 2000;41(2):207-13.
2000: Shengyuan Xu; Mattias Höglund; L Hâkansson; Per Venge
Granulocyte colony-stimulating factor (G-CSF) induces the production of cytokines in vivo.
British journal of haematology 2000;108(4):848-53.
2000: D Lúdvíksdóttir; Christer Janson; Einar Björnsson; Gunnemar Stålenheim; Gunnar Boman; Hans Hedenström; Per Venge; B Gudbjörnsson; S Valtysdóttir
Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness.
Allergy 2000;55(3):259-65.
2000: Christian Olsson; Agneta Siegbahn; E Haldén; Bo Nilsson; Per Venge; Stefan Thelin
No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits.
The Annals of thoracic surgery 2000;69(3):743-9.
2000: Dan Norbäck; Robert Wålinder; Gunilla Wieslander; Greta Smedje; C Erwall; Per Venge
Indoor air pollutants in schools: nasal patency and biomarkers in nasal lavage.
Allergy 2000;55(2):163-70.
2000: Christian Olsson; Agneta Siegbahn; A Henze; Bo Nilsson; Per Venge; P O Joachimsson; Stefan Thelin
Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery.
Scandinavian cardiovascular journal : SCJ 2000;34(1):33-40.
1999: Kawa Amin; David S Hurst; Godfried M Roomans; Per Venge; Lahja Sevéus
Eosinophils and neutrophils in biopsies from the middle ear of atopic children with otitis media with effusion.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1999;48(12):626-31.
1999: I Torsteinsdóttir; L Hâkansson; Roger Hällgren; B Gudbjörnsson; NG Arvidson; Per Venge
Serum lysozyme: a potential marker of monocyte/macrophage activity in rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(12):1249-54.
1999: L Liu; Peter Ridefelt; L Håkansson; Per Venge
Regulation of human eosinophil migration across lung epithelial monolayers by distinct calcium signaling mechanisms in the two cell types.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(10):5649-55.
1999: Gunilla Wieslander; Dan Norbäck; Robert Wålinder; C Erwall; Per Venge
Inflammation markers in nasal lavage, and nasal symptoms in relation to relocation to a newly painted building: a longitudinal study.
International archives of occupational and environmental health 1999;72(8):507-15.
1999: David S Hurst; Kawa Amin; Lahja Sevéus; Per Venge
Mast cells and tryptase in the middle ear of children with otitis media with effusion.
International journal of pediatric otorhinolaryngology 1999;49 Suppl 1():S315-9.
1999: Inger Dahlén; Christer Janson; Einar Björnsson; Gunnemar Stålenheim; C G B Peterson; Per Venge
Inflammatory markers in acute exacerbations of obstructive pulmonary disease: predictive value in relation to smoking history.
Respiratory medicine 1999;93(10):744-51.
1999: Gunilla Wieslander; Dan Norbäck; K Nordström; Robert Wålinder; Per Venge
Nasal and ocular symptoms, tear film stability and biomarkers in nasal lavage, in relation to building-dampness and building design in hospitals.
International archives of occupational and environmental health 1999;72(7):451-61.
1999: Per Venge; Jonas Byström; Marie Carlson; L Hâkansson; M Karawacjzyk; C Peterson; Lahja Sevéus; Agneta Trulson
Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1999;29(9):1172-86.
1999: Marie Carlson; Yngve Raab; C Peterson; Roger Hällgren; Per Venge
Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
The American journal of gastroenterology 1999;94(7):1876-83.
1999: Gustav Fjaertoft; Lena Håkansson; Uwe Ewald; Tony Foucard; Per Venge
Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections.
Pediatric research 1999;45(6):871-6.
1999: D Lúdvíksdóttir; Christer Janson; Marieann Högman; B Gudbjörnsson; Einar Björnsson; Sigrídur Valtýsdóttir; Hans Hedenström; Per Venge; Gunnar Boman
Increased nitric oxide in expired air in patients with Sjögren's syndrome. BHR study group. Bronchial hyperresponsiveness.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1999;13(4):739-43.
1999: Robert Wålinder; Dan Norbäck; Gunilla Wieslander; Greta Smedje; C Erwall; Per Venge
Nasal patency and lavage biomarkers in relation to settled dust and cleaning routines in schools.
Scandinavian journal of work, environment & health 1999;25(2):137-43.
1999: Maria Lampinen; S Rak; Per Venge
The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1999;29(3):314-22.
1999: David S Hurst; Kawa Amin; Lahja Sevéus; Per Venge
Evidence of mast cell activity in the middle ears of children with otitis media with effusion.
The Laryngoscope 1999;109(3):471-7.
1999: Gunnar Frostfeldt; G Ahlberg; G Gustafsson; G Helmius; Bertil Lindahl; Anders Nygren; Agneta Siegbahn; E Swahn; Per Venge; Lars Wallentin
Low molecular weight heparin (dalteparin) as adjuvant treatment of thrombolysis in acute myocardial infarction--a pilot study: biochemical markers in acute coronary syndromes (BIOMACS II).
Journal of the American College of Cardiology 1999;33(3):627-33.
1998: C Woschnagg; S Rak; Per Venge
Blood eosinophils from asymptomatic allergics have a reduced capacity to produce oxygen-free radicals.
Allergy 1998;53(12):1162-71.
1998: Bertil Lindahl; Per Venge; Lars Wallentin
The FRISC experience with troponin T. Use as decision tool and comparison with other prognostic markers.
European heart journal 1998;19 Suppl N():N51-8.
1998: Robert Wålinder; Dan Norbäck; Gunilla Wieslander; Greta Smedje; C Erwall; Per Venge
Nasal patency and biomarkers in nasal lavage--the significance of air exchange rate and type of ventilation in schools.
International archives of occupational and environmental health 1998;71(7):479-86.
1998: G Lilienberg; Per Venge
Platelet adhesion in patients prone to arterial and venous thrombosis: the impact of gender, smoking and heredity.
Scandinavian journal of clinical and laboratory investigation 1998;58(4):279-86.
1998: Lena Håkansson; C Heinrich; Sabina Rak; Per Venge
Activation of B-lymphocytes during pollen season. Effect of immunotherapy.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1998;28(7):791-8.
1998: Per Venge; Jonas Byström
Eosinophil cationic protein (ECP).
The international journal of biochemistry & cell biology 1998;30(4):433-7.
1998: Ilkka Helenius; Paula Rytilä; Tuula Metso; Tari Haahtela; Per Venge; Heikki O Tikkanen
Respiratory symptoms, bronchial responsiveness, and cellular characteristics of induced sputum in elite swimmers.
Allergy 1998;53(4):346-52.
1997: Jan Borowiec; Per Venge; A Henze; Bo Nilsson; H Stiernström
Biomaterial-dependent blood activation during simulated extracorporeal circulation: a study of heparin-coated and uncoated circuits.
The Thoracic and cardiovascular surgeon 1997;45(6):295-301.
1997: Jan Borowiec; A Jaramillo; Per Venge; L Nilsson; Stefan Thelin
Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation.
Cardiovascular surgery (London, England) 1997;5(6):568-73.
1997: Bertil Lindahl; Bertil Andrén; J Ohlsson; Per Venge; Lars Wallentin
Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group.
The American journal of cardiology 1997;80(5A):40E-44E.
1997: L Håkansson; M Höglund; U B Jönsson; I Torsteinsdottir; X Xu; Per Venge
Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion.
British journal of haematology 1997;98(3):603-11.
1997: A Trulson; S Nilsson; Per Venge
The eosinophil granule proteins in serum, but not the oxidative metabolism of the blood eosinophils, are increased in cancer.
British journal of haematology 1997;98(2):312-4.
1997: Jan Borowiec; M Bozdayi; A Jaramillo; L Nilsson; Per Venge; A Henze
Influence of two blood conservation techniques (cardiotomy reservoir versus cell-saver) on biocompatibility of the heparin coated cardiopulmonary bypass circuit during coronary revascularization surgery.
Journal of cardiac surgery 1997;12(3):190-7.
1997: Lahja Sevéus; Kawa Amin; C G B Peterson; Godfried M Roomans; Per Venge
Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral blood cells.
Histochemistry and cell biology 1997;107(5):423-32.
1997: Bertil Lindahl; Bertil Andrén; J Ohlsson; Per Venge; Lars Wallentin
Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group.
European heart journal 1997;18(5):762-70.
1997: Lena Håkansson; C Heinrich; Sabina Rak; Per Venge
Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy.
The Journal of allergy and clinical immunology 1997;99(4):551-62.
1997: M Karawajczyk; M Höglund; J Ericsson; Per Venge
Administration of G-CSF to healthy subjects: the effects on eosinophil counts and mobilization of eosinophil granule proteins.
British journal of haematology 1997;96(2):259-65.
1997: Bertil Lindahl; Per Venge; Lars Wallentin
Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group.
Journal of the American College of Cardiology 1997;29(1):43-8.
1996: Lauri A Laitinen; Annika Laitinen; Alan Altraja; Ismo Virtanen; M Kämpe; B G Simonsson; S E Karlsson; Lena Håkansson; Per Venge; H Sillastu
Bronchial biopsy findings in intermittent or "early" asthma.
The Journal of allergy and clinical immunology 1996;98(5 Pt 2):S3-6; discussion S33-40.
1996: Alan Altraja; Annika Laitinen; Ismo Virtanen; M Kämpe; B G Simonsson; S E Karlsson; Lena Håkansson; Per Venge; H Sillastu; Lauri A Laitinen
Expression of laminins in the airways in various types of asthmatic patients: a morphometric study.
American journal of respiratory cell and molecular biology 1996;15(4):482-8.
1996: O Moen; Erik Fosse; E Dregelid; V Brockmeier; C Andersson; K Høgåsen; Per Venge; Tom Eirik Mollnes; P Kierulf
Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
The Annals of thoracic surgery 1996;62(4):1134-40.
1996: C Woschnagg; Sabina Rak; Per Venge
Oxygen radical production by blood eosinophils is reduced during birch pollen season in allergic patients.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1996;26(9):1064-72.
1996: M Bozdayi; Jan Borowiec; L Nilsson; Per Venge; S Thelin; H E Hansson
Effects of heparin coating of cardiopulmonary bypass circuits on in vitro oxygen free radical production during coronary bypass surgery.
Artificial organs 1996;20(9):1008-16.
1996: S Xu; M Höglund; Per Venge
The effect of granulocyte colony-stimulating factor (G-CSF) on the degranulation of secondary granule proteins from human neutrophils in vivo may be indirect.
British journal of haematology 1996;93(3):558-68.
1996: A Trulson; S Nilsson; Per Venge
Monocyte activation in patients with non-seminomatous germ cell tumour of the testis before and after tumour eradication.
Journal of clinical pathology 1996;49(5):381-5.
1996: Bertil Lindahl; Per Venge; Lars Wallentin
Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group.
Circulation 1996;93(9):1651-7.
1996: B Pedersen; R Dahl; R Karlström; C G Peterson; Per Venge
Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
American journal of respiratory and critical care medicine 1996;153(5):1519-29.
1996: J Venge; M Lampinen; L Håkansson; S Rak; Per Venge
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung.
The Journal of allergy and clinical immunology 1996;97(5):1110-5.
1996: D S Hurst; Per Venge
Levels of eosinophil cationic protein and myeloperoxidase from chronic middle ear effusion in patients with allergy and/or acute infection.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1996;114(4):531-44.
1996: O Moen; Erik Fosse; J Bråten; C Andersson; K Høgåsen; Tom Eirik Mollnes; Per Venge; P Kierulf
Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit.
Perfusion 1996;11(2):113-23.
1996: E Bjornsson; Christer Janson; L Hakansson; I Enander; Per Venge; Gunnar Boman
Eosinophil peroxidase: a new serum marker of atopy and bronchial hyper-responsiveness.
Respiratory medicine 1996;90(1):39-46.
1996: Per Venge; B Pedersen; L Håkansson; R Hällgren; G Lindblad; R Dahl
Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis.
American journal of respiratory and critical care medicine 1996;153(1):312-6.
1995: O Moen; Erik Fosse; V Brockmeier; C Andersson; Tom Eirik Mollnes; K Høgåsen; Per Venge
Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems.
The Annals of thoracic surgery 1995;60(5):1317-23.
1995: M Karawajczyk; K Pauksen; C G Peterson; E Eklund; Per Venge
The differential release of eosinophil granule proteins. Studies on patients with acute bacterial and viral infections.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1995;25(8):713-9.
1995: B Schmekel; Y Hörnblad; M Hvatum; A L Norlund; Per Venge
Kinetic retrieval of eosinophil cationic protein, hyaluronan, secretory IgA, albumin, and urea during BAL in healthy subjects.
Chest 1995;108(1):62-7.
1995: S Y Xu; K Pauksen; Per Venge
Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections.
Scandinavian journal of clinical and laboratory investigation 1995;55(2):125-31.
1995: Bertil Lindahl; Per Venge; Lars Wallentin
Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes.
Coronary artery disease 1995;6(4):321-8.
1995: L Nilsson; C Peterson; Per Venge; Jan Borowiec; S Thelin
Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating.
The Annals of thoracic surgery 1995;59(3):713-6.
1995: Jan Borowiec; L Hagman; T H Tötterman; M Pekna; Per Venge; S Thelin
Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits.
Scandinavian journal of thoracic and cardiovascular surgery 1995;29(4):167-74.
1995: Per Venge
Role of eosinophils in childhood asthma inflammation.
Pediatric pulmonology. Supplement 1995;11():34-5.
1994: E Björnsson; Christer Janson; L Håkansson; I Enander; Per Venge; Gunnar Boman
Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population.
Allergy 1994;49(9):730-6.
1994: Erik Fosse; O Moen; E Johnson; G Semb; V Brockmeier; Tom Eirik Mollnes; Magne Kristoffer Fagerhol; Per Venge
Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass.
The Annals of thoracic surgery 1994;58(2):472-7.
1994: S Y Xu; M Carlson; A Engström; R Garcia; C G Peterson; Per Venge
Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils.
Scandinavian journal of clinical and laboratory investigation 1994;54(5):365-76.
1994: G Edelstam; K Fredens; Per Venge
Role of eosinophilic granulocytes in women with infertility and pelvic adhesions.
Inflammation 1994;18(4):361-71.
1994: S Y Xu; C G Petersson; M Carlson; Per Venge
The development of an assay for human neutrophil lipocalin (HNL)--to be used as a specific marker of neutrophil activity in vivo and vitro.
Journal of immunological methods 1994;171(2):245-52.
1994: J Nielsen; Hans Welinder; H Ottosson; I Bensryd; Per Venge; Staffan Skerfving
Nasal challenge shows pathogenetic relevance of specific IgE serum antibodies for nasal symptoms caused by hexahydrophthalic anhydride.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1994;24(5):440-9.
1994: Per Venge
Eosinophil activity in bronchial asthma.
Allergy proceedings : the official journal of regional and state allergy societies 1994;15(3):139-41.
1994: G A Edelstam; O Lundkvist; Per Venge; T C Laurent
Hyaluronan and myeloperoxidase in human peritoneal fluid during genital inflammation.
Inflammation 1994;18(2):141-9.
1994: Lena Håkansson; Per Venge
Priming of eosinophil and neutrophil migratory responses by interleukin 3 and interleukin 5.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1994;102(4):308-16.
1994: M Höglund; Bengt Simonsson; B Smedmyr; Gunnar Oberg; Per Venge
The effect of rGM-CSF on neutrophil and eosinophil regeneration after ABMT as monitored by circulating levels of granule proteins.
British journal of haematology 1994;86(4):709-16.
1994: O Moen; Erik Fosse; J Bråten; C Andersson; Magne Kristoffer Fagerhol; Per Venge; K Høgåsen; Tom Eirik Mollnes
Roller and centrifugal pumps compared in vitro with regard to haemolysis, granulocyte and complement activation.
Perfusion 1994;9(2):109-17.
1994: A Trulson; S Nilsson; E Brekkan; Per Venge
Patients with renal cancer have a larger proportion of high-density blood monocytes with increased lucigenin-enhanced chemiluminescence.
Inflammation 1994;18(1):99-105.
1994: G A Edelstam; O Lundkvist; Per Venge; T C Laurent
Hyaluronan and myeloperoxidase in human peritoneal fluid during genital inflammation.
Inflammation 1994;18(1):13-21.
1994: Per Venge
Soluble markers of allergic inflammation.
Allergy 1994;49(1):1-8.
1994: M Carlson; Gunnar Oberg; C Peterson; Per Venge
Releasability of human hypereosinophilic eosinophils is related to the density of the cells.
British journal of haematology 1994;86(1):41-7.
1994: M Pekna; Jan Borowiec; Magne Kristoffer Fagerhol; Per Venge; S Thelin
Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass.
Scandinavian journal of thoracic and cardiovascular surgery 1994;28(1):5-11.
1993: M Carlson; C Peterson; Per Venge
The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
Allergy 1993;48(6):437-42.
1993: D S Hurst; Per Venge
The presence of eosinophil cationic protein in middle ear effusion.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 1993;108(6):711-22.
1993: Per Venge
Serum measurements of eosinophil cationic protein (ECP) in bronchial asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1993;23 Suppl 2():3-7, discussion 15-22.
1993: Per Venge
The eosinophil granulocyte in allergic inflammation.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 1993;4(4 Suppl):19-24.
1993: B Schmekel; Per Venge
Markers for eosinophils and T-lymphocytes as predictors of late asthmatic response.
Allergy 1993;48(17 Suppl):94-7; discussion 110-1.
1993: Per Venge
Eosinophil and neutrophil granulocytes.
Allergy 1993;48(17 Suppl):39-47; discussion 48-9.
1992: Jan Borowiec; S Thelin; L Bagge; L Nilsson; Per Venge; H E Hansson
Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.
The Journal of thoracic and cardiovascular surgery 1992;104(3):642-7.
1992: M Carlson; Lena Håkansson; M Kämpe; Gunnemar Stålenheim; C Peterson; Per Venge
Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season.
The Journal of allergy and clinical immunology 1992;89(1 Pt 1):131-9.
1991: Per Venge; J Henriksen; R Dahl
Eosinophils in exercise-induced asthma.
The Journal of allergy and clinical immunology 1991;88(5):699-704.
1991: H Klementsson; Christer Svensson; Morgan Andersson; Per Venge; U Pipkorn; Carl G A Persson
Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1991;21(6):705-10.
1991: B Gudbjörnsson; Nils Feltelius; Roger Hällgren; Per Venge
Neutrophil function in patients with primary Sjögren's syndrome: relation to infection propensity.
Annals of the rheumatic diseases 1991;50(10):685-90.
1991: J Bousquet; Pascal Chanez; J Y Lacoste; I Enander; Per Venge; C Peterson; S Ahlstedt; François-Bernard Michel; Philippe Godard
Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma.
The Journal of allergy and clinical immunology 1991;88(4):649-60.
1991: C G Peterson; I Enander; J Nystrand; A S Anderson; L Nilsson; Per Venge
Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1991;21(5):561-7.
1991: B Schmekel; B Blom-Bülow; Y Hörnblad; L A Laitinen; Margareta Linden; Per Venge
Granulocytes and their secretory products, myeloperoxidase and eosinophil cationic protein, in bronchoalveolar lavage fluids from two lung lobes in normal subjects.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1991;4(7):867-71.
1991: Per Venge; Lena Håkansson
Current understanding of the role of the eosinophil granulocyte in asthma.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1991;21 Suppl 3():31-7.
1991: Vibeke Videm; L Nilsson; Per Venge; Jan L Svennevig
Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass.
Artificial organs 1991;15(2):90-5.
1991: K Fredens; Ronald Dahl; Per Venge
In vitro studies of the interaction between heparin and eosinophil cationic protein.
Allergy 1991;46(1):27-9.
1991: P Matsson; S Ahlstedt; I Enander; C G Peterson; Per Venge
Measurement of specific markers in the monitoring of the bronchial inflammation in asthma.
Annals of the New York Academy of Sciences 1991;629():383-7.
1991: H Klementsson; Per Venge; Morgan Andersson; U Pipkorn
Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes.
Acta oto-laryngologica 1991;111(4):776-84.
1991: M Carlson; Lena Håkansson; C Peterson; Gunnemar Stålenheim; Per Venge
Secretion of granule proteins from eosinophils and neutrophils is increased in asthma.
The Journal of allergy and clinical immunology 1991;87(1 Pt 1):27-33.
1990: J Bousquet; Pascal Chanez; J Y Lacoste; G Barnéon; N Ghavanian; I Enander; Per Venge; S Ahlstedt; J Simony-Lafontaine; Philippe Godard
Eosinophilic inflammation in asthma.
The New England journal of medicine 1990;323(15):1033-9.
1990: H Klementsson; Morgan Andersson; C R Baumgarten; Per Venge; U Pipkorn
Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1990;20(5):539-47.
1990: B Schmekel; Y Hörnblad; Margareta Linden; C Sundström; Per Venge
Myeloperoxidase in human lung lavage. II. Internalization of myeloperoxidase by alveolar macrophages.
Inflammation 1990;14(4):455-61.
1990: B Schmekel; S E Karlsson; Margareta Linden; C Sundström; H Tegner; Per Venge
Myeloperoxidase in human lung lavage. I. A marker of local neutrophil activity.
Inflammation 1990;14(4):447-54.
1990: B Schmekel; Per Wollmer; Per Venge; Margareta Linden; B Blom-Bülow
Transfer of 99mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis.
Thorax 1990;45(7):525-9.
1990: Lena Håkansson; Per Venge
Inhibition of neutrophil and eosinophil chemotactic responses to PAF by the PAF-antagonists WEB-2086, L-652,731, and SRI-63441.
Journal of leukocyte biology 1990;47(5):449-56.
1990: Christer Svensson; Morgan Andersson; Carl G A Persson; Per Venge; U Alkner; U Pipkorn
Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.
The Journal of allergy and clinical immunology 1990;85(5):828-33.
1990: Lena Håkansson; M Carlson; Gunnemar Stålenheim; Per Venge
Migratory responses of eosinophil and neutrophil granulocytes from patients with asthma.
The Journal of allergy and clinical immunology 1990;85(4):743-50.
1990: Per Venge
What is the role of the eosinophil?
Thorax 1990;45(3):161-3.
1990: Per Venge; J Henriksen; R Dahl; Lena Håkansson
Exercise-induced asthma and the generation of neutrophil chemotactic activity.
The Journal of allergy and clinical immunology 1990;85(2):498-504.
1990: L Nilsson; H Tydén; O Johansson; U Nilsson; Gunnar Ronquist; Per Venge; T Aberg; SO Nyström
Bubble and membrane oxygenators--comparison of postoperative organ dysfunction with special reference to inflammatory activity.
Scandinavian journal of thoracic and cardiovascular surgery 1990;24(1):59-64.
1990: L Nilsson; U Nilsson; Per Venge; O Johansson; H Tydén; T Aberg; SO Nyström
Inflammatory system activation during cardiopulmonary bypass as an indicator of biocompatibility: a randomized comparison of bubble and membrane oxygenators.
Scandinavian journal of thoracic and cardiovascular surgery 1990;24(1):53-8.
1990: Per Venge; R Brattsand; L A Laitinen; C G Persson
Which markers of inflammation should be used in therapeutic intervention studies of CB/COAD?
Agents and actions. Supplements 1990;30():289-94.
1990: Per Venge; L Håkansson
Indices of inflammatory activity in CB and COAD. Phagocyte secretion and chemotaxis.
Agents and actions. Supplements 1990;30():219-28.
1990: Per Venge
A critical look at blood samples in CB and COAD.
Agents and actions. Supplements 1990;30():109-19.
1989: B Lavö; Lars Knutson; L Lööf; B Odlind; Per Venge; Roger Hällgren
Challenge with gliadin induces eosinophil and mast cell activation in the jejunum of patients with celiac disease.
The American journal of medicine 1989;87(6):655-60.
1989: Roger Hällgren; Nils Feltelius; R Garcia; Per Venge; U Lindh
Metal content of neutrophil granules is altered in chronic inflammation.
Inflammation 1989;13(4):383-92.
1989: Morgan Andersson; P Andersson; Per Venge; U Pipkorn
Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment.
Allergy 1989;44(5):342-8.
1989: Lena Håkansson; Sabina Rak; R Dahl; Per Venge
The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge.
The Journal of allergy and clinical immunology 1989;83(5):933-9.
1989: A Trulson; S Nilsson; Per Venge
Lucigenin-enhanced chemiluminescence in blood is increased in cancer.
American journal of clinical pathology 1989;91(4):441-5.
1989: Roger Hällgren; L Bjermer; R Lundgren; Per Venge
The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis. Signs of eosinophil activation in the lung are related to impaired lung function.
The American review of respiratory disease 1989;139(2):373-7.
1989: Per Venge; R Dahl
The eosinophil and intrinsic asthma.
Agents and actions. Supplements 1989;28():67-74.
1989: Roger Hällgren; J F Colombel; Ronald Dahl; K Fredens; A Kruse; NO Jacobsen; Per Venge; J C Rambaud
Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents.
The American journal of medicine 1989;86(1):56-64.
1989: Agneta Siegbahn; V Odlind; U Hedner; Per Venge
Coagulation and fibrinolysis during the normal menstrual cycle.
Upsala journal of medical sciences 1989;94(2):137-52.
1988: Per Venge; R Dahl; K Fredens; C G Peterson
Epithelial injury by human eosinophils.
The American review of respiratory disease 1988;138(6 Pt 2):S54-7.
1988: C G Peterson; H Jörnvall; Per Venge
Purification and characterization of eosinophil cationic protein from normal human eosinophils.
European journal of haematology 1988;40(5):415-23.
1988: Per Venge; R Dahl; C G Peterson
Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication.
International archives of allergy and applied immunology 1988;87(3):306-12.
1988: L Nilsson; S Brunnkvist; U Nilsson; SO Nyström; H Tydén; Per Venge; T Aberg
Activation of inflammatory systems during cardiopulmonary bypass.
Scandinavian journal of thoracic and cardiovascular surgery 1988;22(1):51-3.
1987: Lena Håkansson; D Westerlund; Per Venge
New method for the measurement of eosinophil migration.
Journal of leukocyte biology 1987;42(6):689-96.
1987: A Linder; Per Venge; H Deuschl
Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis.
Allergy 1987;42(8):583-90.
1987: Per Venge; L Nilsson; S O Nyström; T Aberg
Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: a model to estimate human turnover of lactoferrin and myeloperoxidase.
European journal of haematology 1987;39(4):339-45.
1987: Agneta Siegbahn; R C Garcia; K Kishi; Kenneth Nilsson; Per Venge
Specific binding of B-CLL cell-derived chemokinetic inhibitory factor (CIF) to human polymorphonuclear leukocytes.
European journal of haematology 1987;39(2):172-9.
1987: C G Peterson; Per Venge
Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin.
The Biochemical journal 1987;245(3):781-7.
1986: Nils Feltelius; U Lindh; Per Venge; Roger Hällgren
Ankylosing spondylitis: a chronic inflammatory disease with iron overload in granulocytes and platelets.
Annals of the rheumatic diseases 1986;45(10):827-31.
1985: B Schmekel; L Håkansson; R Hällgren; E Nöu; Gunnemar Stålenheim; Per Venge
C3b receptor-mediated phagocytosis in sarcoidosis with extra-thoracic manifestations.
European journal of respiratory diseases 1985;67(5):341-5.
1985: B Schmekel; L Håkansson; R Hällgren; E Nou; Gunnemar Stålenheim; Per Venge
Neutrophil phagocytosis in sarcoidosis. Reduced C3b receptor-mediated phagocytosis in active and silent sarcoidosis.
Clinical and experimental immunology 1985;60(1):191-5.
1984: B Schmekel; L Håkansson; R Hällgren; Gunnemar Stålenheim; Per Venge
Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis.
European journal of respiratory diseases 1984;65(8):592-9.
1984: Per Venge; T Foucard; J Henriksen; L Håkansson; A Kreuger
Serum-levels of lactoferrin, lysozyme and myeloperoxidase in normal, infection-prone and leukemic children.
Clinica chimica acta; international journal of clinical chemistry 1984;136(2-3):121-30.
1982: R Hällgren; L Håkansson; B Schmekel; Gunnemar Stålenheim; Per Venge
Kinetic studies of phagocytosis. IV. Cellular defects and humoral inhibition as causes of impaired neutrophil phagocytosis in sarcoidosis.
Clinical and experimental immunology 1982;47(1):169-75.
1982: B Schmekel; R Hällgren; Gunnemar Stålenheim; Per Venge
Indices of inflammatory cell activity and pulmonary function in different stages of sarcoidosis.
Acta medica Scandinavica 1982;211(5):393-9.